- Published: November 2011
Metabolic Endocrinology Cachexia
- ID: 599546
- March 2008
- 20 pages
- Life Science Analytics
"Metabolic Endocrinology Cachexia " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Cachexia Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Top Companies in late stage Cachexia Projects
--Asubio Pharma Co., Ltd.
--DAIICHI SANKYO COMPANY, LIMITED
--Top Companies in early stage Cachexia Projects
--Bolder BioTechnology, Inc.
--Neurocrine Biosciences Inc
--Palatin Technologies Inc
--Santhera Pharmaceuticals AG
--The Quigley Corporation
Full Pipeline View
--Pre Clinical Pipeline View
--Phase II Pipeline View
--On the Market Pipeline View